speb/financial-data huggingface dataset:
Financial ratios for HOVR — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -4313138.686131386
Net income: -7958394.160583941
Capital expenditures: 101459.85401459853
Operating cash flow: -1725547.4452554744
Depreciation & amortization: 37226.27737226277
Net tangible assets: 7781751.824817518
Owner earnings: -8022627.737226278
Return on net tangible assets (%): -103.09539442829004
Buffett classification: The Gruesome
Stock price: 1.75
Shares outstanding: 66825837
Book value: 7892700.729927007
P/B ratio: 14.816881920604828
Market cap (USD): 116945214.75
Debt to equity: 0.0023120318135577546
Current ratio: 7.973295183595614
Quick ratio: 7.973295183595614
Free cash flow (dilution-adjusted): -3586131.3868613136
Buyback yield (%): 0
Retained earnings: -14880291.970802918
Receivables turnover: 0
Capitalized R&D asset: 3296561.93139744
ROCI (R&D-adjusted, %): -26.008244971058144
Rule of 40 score: 0
Financial ratios for HOVR — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -3655000
Net income: -6178571.428571429
Capital expenditures: 381428.5714285715
Operating cash flow: -1862857.142857143
Depreciation & amortization: 40714.28571428572
Net tangible assets: 10227142.857142858
Owner earnings: -6519285.7142857155
Return on net tangible assets (%): -63.74493644363739
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 66825837
Book value: 10335714.285714287
P/B ratio: 10.668119106427088
Market cap (USD): 110262631.05
Debt to equity: 0.0013130615065653074
Current ratio: 6.510220125786163
Quick ratio: 6.510220125786163
Free cash flow (dilution-adjusted): -2499285.7142857146
Buyback yield (%): 0
Retained earnings: -20740000
Receivables turnover: 0
Capitalized R&D asset: 3788739.2437774856
ROCI (R&D-adjusted, %): -18.97630419922735
Rule of 40 score: 0
Financial ratios for IMKTA — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 63.27
Shares outstanding: 14548836
Market cap (USD): 920504853.72
Buyback yield (%): 8.690729622630979
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMKTA — annual report dated 2022-09-30
Total revenue: 5678835032
Gross profit: 1415768360
Operating income: 375574475
Net income: 272758928
Capital expenditures: 2618907
Operating cash flow: 339498470
Depreciation & amortization: 117801654
Net tangible assets: 1259594425
Owner earnings: 387941675
Return on net tangible assets (%): 30.79893553831822
Capex to operating income (%): 0.6973069722057124
Buffett classification: The Great
Stock price: 76.51
P/E ratio: 4.081008275410146
Shares outstanding: 14548836
Book value: 1259594425
P/B ratio: 0.8837221094877425
Market cap (USD): 1113131442.3600001
Debt to equity: 0.4862682628974005
Current ratio: 2.5110525109169353
Quick ratio: 1.1390422494924615
Effective tax rate (%): 24.4999633625747
Interest coverage ratio: 17.46197310924448
COGS to revenue (%): 75.06938743558838
SG&A to revenue (%): 0.19194077550376004
Free cash flow (dilution-adjusted): 219889496
Buyback yield (%): 0
Retained earnings: 1246238155
Inventory turnover: 9.309112785134042
Receivables turnover: 58.44971688991868
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.145028704849565
FCF margin (%): 3.872088108933114
Rule of 40 score: 3.872088108933114
Financial ratios for IMKTA — annual report dated 2023-09-30
Total revenue: 5892781732
Gross profit: 1404915214
Operating income: 289534381
Net income: 210811959
Capital expenditures: 3495707
Operating cash flow: 266411341
Depreciation & amortization: 115979172
Net tangible assets: 1458972140
Owner earnings: 323295424
Return on net tangible assets (%): 22.159122517582823
Capex to operating income (%): 1.2073547148101904
Buffett classification: The Great
Stock price: 73.31
P/E ratio: 5.059367467668189
Shares outstanding: 14548836
Book value: 1458972140
P/B ratio: 0.7310456025294629
Market cap (USD): 1066575167.1600001
Debt to equity: 0.4081403411856788
Current ratio: 2.88187840730008
Quick ratio: 1.387747556902379
Effective tax rate (%): 24.305850869966015
Interest coverage ratio: 13.119928231865723
COGS to revenue (%): 76.1587094534524
SG&A to revenue (%): 0.17988108981600406
Free cash flow (dilution-adjusted): 92819873
Buyback yield (%): 0
Retained earnings: 1444788790
Inventory turnover: 9.087329531950644
Receivables turnover: 54.78055157961709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.50873331129567
FCF margin (%): 1.5751452747002916
Revenue growth (%): 3.7674399554559908
Rule of 40 score: 5.342585230156282
Financial ratios for IMKTA — annual report dated 2024-09-30
Total revenue: 5639609434
Gross profit: 1299835277
Operating income: 142538184
Net income: 105541301
Capital expenditures: 4670841
Operating cash flow: 262516708
Depreciation & amortization: 121622579
Net tangible assets: 1545749090
Owner earnings: 222493039
Return on net tangible assets (%): 14.393865112998386
Capex to operating income (%): 3.276905085306826
Buffett classification: The Great
Stock price: 73.23
P/E ratio: 10.094733058861953
Shares outstanding: 14548836
Book value: 1545749090
P/B ratio: 0.6892523936598274
Market cap (USD): 1065411260.2800001
Debt to equity: 0.36548947992587855
Current ratio: 2.8867261655677567
Quick ratio: 1.445512715748489
Effective tax rate (%): 24.343858986662784
Interest coverage ratio: 6.520562127741333
COGS to revenue (%): 76.95167915062396
SG&A to revenue (%): 0.17199772632340057
Free cash flow (dilution-adjusted): 51661106
Buyback yield (%): 0
Retained earnings: 1538061740
Inventory turnover: 9.39172959297861
Receivables turnover: 72.05659975368991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.4576957046820995
FCF margin (%): 0.9160404918919781
Revenue growth (%): -4.296312158062467
Rule of 40 score: -3.3802716661704886
Financial ratios for IMKTA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 73.23
Shares outstanding: 14548836
Market cap (USD): 1065411260.2800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMKTA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 63.42
Shares outstanding: 14548836
Market cap (USD): 922687179.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMKTA — quarterly report dated 2025-03-31
Total revenue: 1331273155
Gross profit: 310976634
Operating income: 21832625
Net income: 15106015
Capital expenditures: 163754
Operating cash flow: 63059866
Depreciation & amortization: 30597103
Net tangible assets: 1571812858
Owner earnings: 45539364
Return on net tangible assets (%): 2.897251016125738
Capex to operating income (%): 0.7500426540555706
Buffett classification: The Great
Stock price: 64.27
P/E ratio: 15.474857030792037
Shares outstanding: 14548836
Book value: 1571812858
P/B ratio: 0.5948886885362277
Market cap (USD): 935053689.7199999
Debt to equity: 0.35188297397170165
Current ratio: 3.1854598384572173
Quick ratio: 1.46448879387722
Effective tax rate (%): 22.94427952641334
Interest coverage ratio: 4.475204444903595
COGS to revenue (%): 76.64065914406574
Free cash flow (dilution-adjusted): 38858999
Buyback yield (%): 0
Retained earnings: 1563621421
Inventory turnover: 2.077224907396385
Receivables turnover: 13.420165882764518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9830036483816753
FCF margin (%): 2.918935070090856
Rule of 40 score: 2.918935070090856
Financial ratios for IMKTA — quarterly report dated 2025-06-30
Total revenue: 1346221519
Gross profit: 327330170
Operating income: 37198425
Net income: 26198955
Capital expenditures: 392826
Operating cash flow: 74785565
Depreciation & amortization: 30678180
Net tangible assets: 1593856798
Owner earnings: 56484309
Return on net tangible assets (%): 3.5438760289429716
Capex to operating income (%): 1.0560285818552801
Buffett classification: The Great
Stock price: 62.7
P/E ratio: 22.084800381164786
Shares outstanding: 14548836
Book value: 1593856798
P/B ratio: 0.5723299723944208
Market cap (USD): 912212017.2
Debt to equity: 0.34391706876542116
Current ratio: 3.1440401344808753
Quick ratio: 1.5265372615770498
Effective tax rate (%): 25.68716936385254
Interest coverage ratio: 7.66017075902533
COGS to revenue (%): 75.68526684648843
Free cash flow (dilution-adjusted): 45378059
Buyback yield (%): 0
Retained earnings: 1586753010
Inventory turnover: 2.0898426726865313
Receivables turnover: 13.162313457351853
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6564059779178848
FCF margin (%): 3.370772072764646
Revenue growth (%): 1.1228622723936772
Rule of 40 score: 4.493634345158323
Financial ratios for IMKTA — annual report dated 2025-09-30
Total revenue: 5334032609
Gross profit: 1274140591
Operating income: 145596316
Net income: 83592501
Capital expenditures: 4564647
Operating cash flow: 154097893
Depreciation & amortization: 122890499
Net tangible assets: 1615931577
Owner earnings: 201918353
Return on net tangible assets (%): 12.495476657177793
Capex to operating income (%): 3.1351390786563584
Buffett classification: The Great
Stock price: 68.99
P/E ratio: 12.007347353322995
Shares outstanding: 14548836
Book value: 1615931577
P/B ratio: 0.6211427574819895
Market cap (USD): 1003724195.6399999
Debt to equity: 0.33644324904482015
Current ratio: 3.2206951988687664
Quick ratio: 1.6261914172520802
Effective tax rate (%): 23.963615472758473
Interest coverage ratio: 7.38677407253813
COGS to revenue (%): 76.11299584389174
SG&A to revenue (%): 0.13873181029141324
Free cash flow (dilution-adjusted): 39597305
Buyback yield (%): 0
Retained earnings: 1609384834
Inventory turnover: 8.405933268407159
Receivables turnover: 50.15298172791555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.433342205177952
FCF margin (%): 0.7423521358528687
Revenue growth (%): -5.418404032693162
Rule of 40 score: -4.676051896840293
Financial ratios for IMKTA — quarterly report dated 2025-09-30
Total revenue: 1368423268
Gross profit: 334699071
Operating income: 66139523
Net income: 25699191
Capital expenditures: 91374
Operating cash flow: 59899755
Depreciation & amortization: 30676692
Net tangible assets: 1615931577
Owner earnings: 56284509
Return on net tangible assets (%): 3.483099767410511
Capex to operating income (%): 0.13815340035034726
Buffett classification: The Great
Stock price: 68.99
P/E ratio: 14.980027817078405
Shares outstanding: 14548836
Book value: 1615931577
P/B ratio: 0.6211427574819895
Market cap (USD): 1003724195.6399999
Debt to equity: 0.33644324904482015
Current ratio: 3.2206951988687664
Quick ratio: 1.6261914172520802
Effective tax rate (%): 22.639845749231245
Interest coverage ratio: 13.321801989140257
COGS to revenue (%): 75.54126133143185
Free cash flow (dilution-adjusted): 36783627
Buyback yield (%): 0
Retained earnings: 1609384834
Inventory turnover: 2.1403073232968377
Receivables turnover: 12.866533106726736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.922451586936017
FCF margin (%): 2.6880299290555474
Revenue growth (%): 1.6491898760088088
Rule of 40 score: 4.337219805064356
Financial ratios for IMKTA — quarterly report dated 2025-12-31
Total revenue: 1372977567
Gross profit: 334557704
Operating income: 39141777
Net income: 28128370
Capital expenditures: 63742
Operating cash flow: 38405324
Depreciation & amortization: 30293021
Net tangible assets: 1640463009
Owner earnings: 58357649
Return on net tangible assets (%): 3.557388900562524
Capex to operating income (%): 0.16284901934830398
Buffett classification: The Great
Stock price: 68.14
P/E ratio: 10.420806370010276
Shares outstanding: 14548836
Book value: 1640463009
P/B ratio: 0.6043157813380479
Market cap (USD): 991357685.04
Debt to equity: 0.328584736774153
Current ratio: 3.3580890350270427
Quick ratio: 1.6902750183385815
Effective tax rate (%): 24.881580820272305
Interest coverage ratio: 8.496018404744184
COGS to revenue (%): 75.63268970730387
Free cash flow (dilution-adjusted): 2053070
Buyback yield (%): 0
Retained earnings: 1634445818
Inventory turnover: 2.1397903069101836
Receivables turnover: 12.558079363217958
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7169295622532907
FCF margin (%): 0.1495341256365917
Revenue growth (%): 0.33281361889265976
Rule of 40 score: 0.48234774452925144
Financial ratios for JBGS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.61
Shares outstanding: 58255895
Market cap (USD): 1375421680.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBGS — annual report dated 2022-12-31
Total revenue: 605824000
Gross profit: 299124000
Operating income: 21682000
Net income: 98986000
Capital expenditures: 326741000
Operating cash flow: 178037000
Depreciation & amortization: 217841000
Net tangible assets: 2613710000
Owner earnings: -9914000
Return on net tangible assets (%): -0.3793075742909504
Capex to operating income (%): 1506.9689143067983
Buffett classification: The Gruesome
Stock price: 16.28
P/E ratio: 9.581213207928394
Shares outstanding: 58255895
Book value: 3195422000
P/B ratio: 0.2968014774261428
Market cap (USD): 948405970.6
Debt to equity: 0.7652200554418165
Current ratio: 3.089938633476661
Quick ratio: 3.089938633476661
Effective tax rate (%): 1.260847880299252
Interest coverage ratio: 0.2763833828347079
COGS to revenue (%): 50.62526410310585
SG&A to revenue (%): 10.509818032960068
Free cash flow (dilution-adjusted): -189976000
Buyback yield (%): 38.06829682562945
Retained earnings: -628636000
Receivables turnover: 2.667324152020006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.37801461951752835
FCF margin (%): -31.358282273399535
Rule of 40 score: -31.358282273399535
Financial ratios for JBGS — annual report dated 2023-12-31
Total revenue: 604198000
Gross profit: 313533000
Operating income: 47951000
Net income: -79978000
Capital expenditures: 333744000
Operating cash flow: 183372000
Depreciation & amortization: 215628000
Net tangible assets: 2166260000
Owner earnings: -198094000
Return on net tangible assets (%): -9.14451635537747
Capex to operating income (%): 696.0105107297032
Buffett classification: The Gruesome
Stock price: 15.28
Shares outstanding: 58255895
Book value: 2692586000
P/B ratio: 0.3305929970667604
Market cap (USD): 890150075.5999999
Debt to equity: 0.9755257585087347
Current ratio: 2.2962851975127627
Quick ratio: 2.2962851975127627
Interest coverage ratio: 0.526592648722257
COGS to revenue (%): 48.10757400719632
SG&A to revenue (%): 9.167028027236105
Free cash flow (dilution-adjusted): -182472000
Buyback yield (%): 37.66926602505588
Retained earnings: -776962000
Receivables turnover: 2.804223521767381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8993666302738688
FCF margin (%): -30.200695798397213
Revenue growth (%): -0.26839478132262834
Rule of 40 score: -30.46909057971984
Financial ratios for JBGS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 51746000
Buffett classification: The Gruesome
Stock price: 16.24
Shares outstanding: 58255895
Market cap (USD): 946075734.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBGS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.59
Shares outstanding: 58255895
Market cap (USD): 849953508.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBGS — annual report dated 2024-12-31
Total revenue: 547312000
Gross profit: 273833000
Operating income: 6863000
Net income: -143526000
Capital expenditures: 218029000
Operating cash flow: 129393000
Depreciation & amortization: 214992000
Net tangible assets: 1762058000
Owner earnings: -146563000
Return on net tangible assets (%): -8.317717123953921
Capex to operating income (%): 3176.8760017485065
Buffett classification: The Gruesome
Stock price: 14.59
Shares outstanding: 58255895
Book value: 2232690000
P/B ratio: 0.3806858578889143
Market cap (USD): 849953508.05
Debt to equity: 1.1709892551137866
Current ratio: 1.89463266343447
Quick ratio: 1.89463266343447
Interest coverage ratio: 0.058869445874077886
COGS to revenue (%): 49.96766012804397
SG&A to revenue (%): 10.741587979068612
Free cash flow (dilution-adjusted): -118160000
Buyback yield (%): 20.09168717848908
Retained earnings: -997283000
Receivables turnover: 2.8265721914362887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.14250616495415633
FCF margin (%): -21.589148419914054
Revenue growth (%): -9.415125505215178
Rule of 40 score: -31.004273925129233
Financial ratios for JBGS — quarterly report dated 2025-03-31
Total revenue: 120686000
Gross profit: 59006000
Operating income: -4138000
Net income: -45720000
Capital expenditures: 29091000
Operating cash flow: 12935000
Depreciation & amortization: 49451000
Net tangible assets: 1525467000
Owner earnings: -25360000
Return on net tangible assets (%): -1.662441730958454
Buffett classification: The Gruesome
Stock price: 15.29
Shares outstanding: 58255895
Book value: 1989228000
P/B ratio: 0.4477780498515001
Market cap (USD): 890732634.55
Debt to equity: 1.2820471057113614
Current ratio: 1.2781004132442624
Quick ratio: 1.2781004132442624
Interest coverage ratio: -0.1331145853438847
COGS to revenue (%): 51.10783355153041
SG&A to revenue (%): 12.890476111562235
Free cash flow (dilution-adjusted): -23321000
Buyback yield (%): 16.569843101635577
Retained earnings: -1043003000
Receivables turnover: 0.6238292153416727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09240167082228555
FCF margin (%): -19.323699517756822
Rule of 40 score: -19.323699517756822
Financial ratios for JBGS — quarterly report dated 2025-06-30
Total revenue: 126479000
Gross profit: 65391000
Operating income: 1111000
Net income: -19241000
Capital expenditures: 33326000
Operating cash flow: 18817000
Depreciation & amortization: 49413000
Net tangible assets: 1269930000
Owner earnings: -3154000
Return on net tangible assets (%): -0.2483601458348098
Capex to operating income (%): 2999.6399639963997
Buffett classification: The Gruesome
Stock price: 16.61
Shares outstanding: 58255895
Book value: 1865996000
P/B ratio: 0.5185597482256125
Market cap (USD): 967630415.9499999
Debt to equity: 1.3545200525617418
Current ratio: 0.9635836350188797
Quick ratio: 0.9635836350188797
Interest coverage ratio: 0.034833045931964256
COGS to revenue (%): 48.298927094616495
SG&A to revenue (%): 13.219585860103258
Free cash flow (dilution-adjusted): -22231000
Buyback yield (%): 23.279032602426952
Retained earnings: -1074678000
Receivables turnover: 0.6417615092271706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.02619648495517713
FCF margin (%): -17.576830936360977
Revenue growth (%): 4.800059658949671
Rule of 40 score: -12.776771277411306
Financial ratios for JBGS — quarterly report dated 2025-09-30
Total revenue: 123870000
Gross profit: 60964000
Operating income: -414000
Net income: -28555000
Capital expenditures: 29751000
Operating cash flow: 8873000
Depreciation & amortization: 50088000
Net tangible assets: 1138593000
Owner earnings: -8218000
Return on net tangible assets (%): -0.7217680066538262
Buffett classification: The Gruesome
Stock price: 21.55
Shares outstanding: 58255895
Book value: 1756781000
P/B ratio: 0.7146107211143563
Market cap (USD): 1255414537.25
Debt to equity: 1.4218533784233778
Current ratio: 1.3029471353677131
Quick ratio: 1.3029471353677131
Interest coverage ratio: -0.013260730301089046
COGS to revenue (%): 50.783886332445306
SG&A to revenue (%): 10.667635424235085
Free cash flow (dilution-adjusted): -25845000
Buyback yield (%): 5.013164825848045
Retained earnings: -1114062000
Receivables turnover: 0.6082494475816351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.009909716261365656
FCF margin (%): -20.864616129813516
Revenue growth (%): -2.0627930328354904
Rule of 40 score: -22.927409162649006
Financial ratios for JBGS — quarterly report dated 2025-12-31
Total revenue: 127563000
Gross profit: 62066000
Operating income: 1635000
Net income: -45547000
Capital expenditures: 30104000
Operating cash flow: 32632000
Depreciation & amortization: 48590000
Net tangible assets: 1127257000
Owner earnings: -27061000
Return on net tangible assets (%): -2.400606072971825
Capex to operating income (%): 1841.2232415902142
Buffett classification: The Gruesome
Stock price: 16.81
Shares outstanding: 58255895
Book value: 1668932000
P/B ratio: 0.5867714172596606
Market cap (USD): 979281594.9499999
Debt to equity: 1.523926678858096
Current ratio: 1.0487565704323938
Quick ratio: 1.0487565704323938
Interest coverage ratio: 0.04911975004506399
COGS to revenue (%): 51.34482569397082
SG&A to revenue (%): 10.722544938579368
Free cash flow (dilution-adjusted): -2474000
Buyback yield (%): 0.8036503535432855
Retained earnings: -1180410000
Receivables turnover: 0.6231674491087
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.040021354513564304
FCF margin (%): -1.939433848372961
Revenue growth (%): 2.981351416807944
Rule of 40 score: 1.0419175684349828
Financial ratios for JBGS — annual report dated 2025-12-31
Total revenue: 498598000
Gross profit: 247427000
Operating income: -1806000
Net income: -139063000
Capital expenditures: 122272000
Operating cash flow: 73257000
Depreciation & amortization: 197473000
Net tangible assets: 1127257000
Owner earnings: -63862000
Return on net tangible assets (%): -5.665256458819949
Buffett classification: The Gruesome
Stock price: 16.81
Shares outstanding: 58255895
Book value: 1668932000
P/B ratio: 0.5867714172596606
Market cap (USD): 979281594.9499999
Debt to equity: 1.523926678858096
Current ratio: 1.0487565704323938
Quick ratio: 1.0487565704323938
Interest coverage ratio: -0.0141661502741456
COGS to revenue (%): 50.37545276956587
SG&A to revenue (%): 11.867075279082547
Free cash flow (dilution-adjusted): -73871000
Buyback yield (%): 45.30402718562805
Retained earnings: -1180410000
Receivables turnover: 2.435737978808115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.04420707415993708
FCF margin (%): -14.815743344337523
Revenue growth (%): -8.900590522407695
Rule of 40 score: -23.716333866745217
Financial ratios for KANANIIND.NS — annual report dated 2022-03-31
Total revenue: 38339074.24502176
Gross profit: 741817.2227350653
Operating income: 223935.11802716603
Net income: 238072.0031649743
Capital expenditures: 14136.885137808256
Operating cash flow: -233759.72570222866
Depreciation & amortization: 11881.8409600422
Net tangible assets: 7754569.4316233685
Owner earnings: 235816.95898720826
Return on net tangible assets (%): 3.0410064809728774
Capex to operating income (%): 6.312937989517698
Buffett classification: The Great
Stock price: 0.14743505209020177
P/E ratio: 122.5372093280895
Shares outstanding: 197868000
Book value: 7754569.431623368
P/B ratio: 3.76199854088829
Market cap (USD): 29172678.886984043
Debt to equity: 0.4163638187912501
Current ratio: 1.7232785937120911
Quick ratio: 1.318366731772588
Effective tax rate (%): 10.326329906124274
Interest coverage ratio: 2.167602757212152
COGS to revenue (%): 98.06511441044671
SG&A to revenue (%): 0.08557909668649294
Free cash flow (dilution-adjusted): -247896.61084003694
Buyback yield (%): 0
Retained earnings: 5895898.720822893
Inventory turnover: 8.627602882121707
Receivables turnover: 2.8510017357535817
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.859095952546517
FCF margin (%): -0.6465899756883821
Rule of 40 score: -0.6465899756883821
Financial ratios for KANANIIND.NS — annual report dated 2023-03-31
Total revenue: 32947259.439707674
Gross profit: 864348.3556638247
Operating income: 389013.39829476253
Net income: 264677.22289890377
Capital expenditures: 4068.2095006090135
Operating cash flow: -238294.7624847747
Depreciation & amortization: 8477.466504263095
Net tangible assets: 7632630.937880634
Owner earnings: 269086.47990255785
Return on net tangible assets (%): 3.5254747948978595
Capex to operating income (%): 1.0457761913707808
Buffett classification: The Great
Stock price: 0.03654080389768575
P/E ratio: 27.31725724804418
Shares outstanding: 197868000
Book value: 7632630.937880633
P/B ratio: 0.9472822470353744
Market cap (USD): 7230255.785627284
Debt to equity: 0.5003997516911651
Current ratio: 2.254934819867389
Quick ratio: 1.804319373993733
Effective tax rate (%): 6.291776273232998
Interest coverage ratio: 4.079448205390216
COGS to revenue (%): 97.37656979559847
SG&A to revenue (%): 0.060037634428477954
Free cash flow (dilution-adjusted): -238294.7624847747
Buyback yield (%): 0
Retained earnings: 5710304.506699148
Inventory turnover: 10.1195478871562
Receivables turnover: 2.849682580819158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.390054817266615
FCF margin (%): -0.7232612561322307
Revenue growth (%): -14.063497649566228
Rule of 40 score: -14.78675890569846
Financial ratios for KANANIIND.NS — annual report dated 2024-03-31
Total revenue: 26719498.74085622
Gross profit: 425146.90010792663
Operating income: 64588.08010552824
Net income: 74025.66254946636
Capital expenditures: 0
Operating cash flow: 2300983.3313346924
Depreciation & amortization: 2890.0347763520804
Net tangible assets: 7585873.6059479555
Owner earnings: 76915.69732581844
Return on net tangible assets (%): 1.0139332833796513
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.04378598848368522
P/E ratio: 117.03841169270675
Shares outstanding: 197868000
Book value: 7585873.605947955
P/B ratio: 1.1421026000877017
Market cap (USD): 8663845.969289828
Debt to equity: 0.09405519565719128
Current ratio: 3.6833951296945457
Quick ratio: 3.014017982546581
Effective tax rate (%): 7.811799850634801
Interest coverage ratio: 0.7919423614174387
COGS to revenue (%): 98.40885151240563
SG&A to revenue (%): 0.11408623968253327
Free cash flow (dilution-adjusted): 2300983.3313346924
Buyback yield (%): 0
Retained earnings: 4509581.484590478
Inventory turnover: 12.744617781084349
Receivables turnover: 2.9562285229066885
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7782292322897221
FCF margin (%): 8.611626114887805
Revenue growth (%): -18.902211609581787
Rule of 40 score: -10.290585494693982
Financial ratios for KANANIIND.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 7593060.200668897
Buffett classification: The Gruesome
Stock price: 0.03368370759675107
Shares outstanding: 197868000
Book value: 7593060.2006688975
P/B ratio: 0.8777657069236466
Market cap (USD): 6664927.854753941
Debt to equity: 0
Current ratio: 3.8201825467497774
Quick ratio: 3.2539982190560997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KANANIIND.NS — quarterly report dated 2024-12-31
Total revenue: 2432136.612658818
Gross profit: 87271.24373470101
Operating income: 48210.74717333022
Net income: 82701.94661382445
Capital expenditures: 0
Depreciation & amortization: 617.7876209348409
Owner earnings: 83319.7342347593
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.031472199557057934
P/E ratio: 18.8246511627907
Shares outstanding: 197868000
Market cap (USD): 6227341.181955939
Effective tax rate (%): 4.108663332882822
Interest coverage ratio: 4136
COGS to revenue (%): 96.41174581721805
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KANANIIND.NS — annual report dated 2025-03-31
Total revenue: 19695031.564180497
Gross profit: 192284.31143324758
Operating income: 34381.57587093757
Net income: 91033.43465045592
Capital expenditures: 5412.672433949029
Operating cash flow: 658873.0418517652
Depreciation & amortization: 2408.230067804536
Net tangible assets: 7581038.110825344
Owner earnings: 88028.99228431143
Return on net tangible assets (%): 1.1611733247800249
Capex to operating income (%): 15.7429445766746
Buffett classification: The Great
Stock price: 0.01925545571245186
P/E ratio: 41.8531776323826
Shares outstanding: 197868000
Book value: 7581038.110825343
P/B ratio: 0.5025747734298922
Market cap (USD): 3810038.5109114246
Debt to equity: 0.0007556107956735886
Current ratio: 3.3060348053558766
Quick ratio: 2.597628559922164
Effective tax rate (%): 3.804817788758493
Interest coverage ratio: 226.23076923076925
COGS to revenue (%): 99.02369127560601
SG&A to revenue (%): 0.08286277840795435
Free cash flow (dilution-adjusted): 658873.0418517652
Buyback yield (%): 0
Retained earnings: 4487269.113864859
Inventory turnover: 8.392899366607805
Receivables turnover: 2.3739653525199316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4531782573054
FCF margin (%): 3.345376927702226
Revenue growth (%): -26.289666751624942
Rule of 40 score: -22.944289823922716
Financial ratios for KANANIIND.NS — quarterly report dated 2025-03-31
Total revenue: 3941126.9581482345
Gross profit: 9364.040215104043
Operating income: -30418.517652560204
Net income: -28372.691138648584
Capital expenditures: 0
Depreciation & amortization: 596.2122983399579
Net tangible assets: 7581038.110825344
Owner earnings: -27776.478840308628
Return on net tangible assets (%): -0.36639413275927474
Buffett classification: The Gruesome
Stock price: 0.01925545571245186
Shares outstanding: 197868000
Book value: 7581038.110825343
P/B ratio: 0.5025747734298922
Market cap (USD): 3810038.5109114246
Debt to equity: 0.0007556107956735886
Current ratio: 3.3060348053558766
Quick ratio: 2.597628559922164
Interest coverage ratio: -2602
COGS to revenue (%): 99.76240196485566
Buyback yield (%): 0
Retained earnings: 4487269.113864859
Inventory turnover: 1.6920124162981522
Receivables turnover: 0.4750486851487046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.40094179718077205
Revenue growth (%): 62.043815204927355
Rule of 40 score: 62.043815204927355
Financial ratios for KANANIIND.NS — quarterly report dated 2025-06-30
Total revenue: 9793423.824011235
Gross profit: 75590.91972852797
Operating income: 35420.07956938919
Net income: 33138.310320617835
Capital expenditures: 0
Depreciation & amortization: 409.5483267025509
Owner earnings: 33547.85864732038
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.024806927217411658
P/E ratio: 56.11791102217754
Shares outstanding: 197868000
Market cap (USD): 4908497.07465481
Effective tax rate (%): 2.814001372683596
Interest coverage ratio: 1513.5
COGS to revenue (%): 99.22814614085019
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 148.49298000318015
Rule of 40 score: 148.49298000318015
Financial ratios for KANANIIND.NS — quarterly report dated 2025-09-30
Total revenue: 5492390.0789177
Gross profit: 99684.32919954904
Operating income: 58229.98872604284
Net income: 152931.2288613303
Capital expenditures: 0
Depreciation & amortization: 417.1364148816234
Net tangible assets: 7534351.7474633595
Owner earnings: 153348.36527621193
Return on net tangible assets (%): 2.035322618536369
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.021758737316798196
P/E ratio: 17.909232205348083
Shares outstanding: 197868000
Book value: 7534351.7474633595
P/B ratio: 0.571430426891038
Market cap (USD): 4305357.835400226
Debt to equity: 0.004848143864180148
Current ratio: 3.3559057888163797
Quick ratio: 2.916163304075566
Effective tax rate (%): 8.400297116618272
Interest coverage ratio: 737.8571428571429
COGS to revenue (%): 98.18504644121722
Buyback yield (%): 0
Inventory turnover: 3.8266946135569087
Receivables turnover: 0.5972814453187258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7691311126564879
Revenue growth (%): -43.91756981402545
Rule of 40 score: -43.91756981402545
Financial ratios for KANANIIND.NS — quarterly report dated 2025-12-31
Total revenue: 3171460.398796926
Gross profit: 52155.508521777876
Operating income: 9568.898295644425
Net income: 43299.54327726412
Capital expenditures: 0
Depreciation & amortization: 423.3039991088337
Owner earnings: 43722.84727637296
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.01849170101370168
P/E ratio: 18.20388849839408
Shares outstanding: 197868000
Market cap (USD): 3658915.8961791242
Effective tax rate (%): 7.628326996197718
Interest coverage ratio: 859
COGS to revenue (%): 98.35547344240643
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -42.25718943433318
Rule of 40 score: -42.25718943433318
Financial ratios for MDWD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.52
Shares outstanding: 12852255
Market cap (USD): 212319252.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDWD — annual report dated 2022-12-31
Total revenue: 7527272.7272727275
Gross profit: 3740056.8181818184
Operating income: -2176420.4545454546
Net income: -5567897.7272727275
Capital expenditures: 157670.45454545456
Operating cash flow: -3376420.4545454546
Depreciation & amortization: 361363.63636363635
Net tangible assets: 3034943.1818181816
Owner earnings: -5364204.545454545
Return on net tangible assets (%): -176.7481044650379
Buffett classification: The Gruesome
Stock price: 13.49
Shares outstanding: 12852255
Book value: 3100568.1818181816
P/B ratio: 55.9177898317757
Market cap (USD): 173376919.95
Debt to equity: 0.07751511819681144
Current ratio: 3.801940781288878
Quick ratio: 3.639130795388571
COGS to revenue (%): 50.31325483091788
R&D to revenue (%): 38.424667874396135
SG&A to revenue (%): 39.14175724637681
Free cash flow (dilution-adjusted): -4086931.8181818184
Buyback yield (%): 0
Retained earnings: -47757386.36363637
Inventory turnover: 6.791136016301579
Receivables turnover: 2.7329551315110883
Capitalized R&D asset: 2892329.5454545454
ROCI (R&D-adjusted, %): -1.814845589253567
FCF margin (%): -54.29498792270532
Rule of 40 score: -54.29498792270532
Financial ratios for MDWD — annual report dated 2023-12-31
Total revenue: 5161878.453038674
Gross profit: 988397.7900552485
Operating income: -4282044.198895028
Net income: -1855248.6187845303
Capital expenditures: 1785635.359116022
Operating cash flow: -2890883.9779005526
Depreciation & amortization: 359944.75138121546
Net tangible assets: 8682320.44198895
Owner earnings: -3280939.226519337
Return on net tangible assets (%): -37.78873687559656
Buffett classification: The Gruesome
Stock price: 10.17
Shares outstanding: 12852255
Book value: 8727900.552486187
P/B ratio: 14.975816069852826
Market cap (USD): 130707433.35
Debt to equity: 0.2009811679063143
Current ratio: 2.7417931034482756
Quick ratio: 2.5847724137931034
Interest coverage ratio: -36.30210772833724
COGS to revenue (%): 80.8519747404474
R&D to revenue (%): 39.960398159049554
SG&A to revenue (%): 60.88515466124371
Free cash flow (dilution-adjusted): -5212430.939226519
Buyback yield (%): 0
Retained earnings: -48293370.165745854
Inventory turnover: 5.3085031623331
Receivables turnover: 4.228558497397602
Capitalized R&D asset: 4000567.9777749875
ROCI (R&D-adjusted, %): -22.308114399557436
Rosenberg metric: -0.9513642843537498
FCF margin (%): -100.97934282350423
Revenue growth (%): -31.4243200683268
Rule of 40 score: -132.40366289183103
Financial ratios for MDWD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.06
Shares outstanding: 12852255
Market cap (USD): 232111725.29999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDWD — quarterly report dated 2024-12-31
Total revenue: 1600000
Gross profit: 247397.2602739726
Operating income: -1666575.3424657534
Net income: -1070684.9315068494
Capital expenditures: 220821.91780821918
Operating cash flow: -448493.1506849315
Depreciation & amortization: 108767.12328767123
Net tangible assets: 8507945.205479452
Owner earnings: -1182739.7260273972
Return on net tangible assets (%): -13.901590777355574
Buffett classification: The Gruesome
Stock price: 17.8
Shares outstanding: 12852255
Book value: 8535068.493150685
P/B ratio: 26.80355045581485
Market cap (USD): 228770139
Debt to equity: 0.2090649375662055
Current ratio: 1.9653743265136958
Quick ratio: 1.8639463471609963
COGS to revenue (%): 84.53767123287672
R&D to revenue (%): 51.130136986301366
SG&A to revenue (%): 69.21232876712328
Free cash flow (dilution-adjusted): -894520.5479452056
Buyback yield (%): 0
Retained earnings: -56176986.30136986
Inventory turnover: 1.8339524517087669
Receivables turnover: 0.9979494190020505
Capitalized R&D asset: 818082.1917808219
ROCI (R&D-adjusted, %): -8.194335983126756
FCF margin (%): -55.90753424657535
Rule of 40 score: -55.90753424657535
Financial ratios for MDWD — annual report dated 2024-12-31
Total revenue: 5540273.97260274
Gross profit: 721643.8356164384
Operating income: -5310136.98630137
Net income: -8280547.94520548
Capital expenditures: 1718630.1369863015
Operating cash flow: -3732602.7397260275
Depreciation & amortization: 406301.36986301374
Net tangible assets: 8507945.205479452
Owner earnings: -9592876.712328767
Return on net tangible assets (%): -112.75198042120178
Buffett classification: The Gruesome
Stock price: 17.8
Shares outstanding: 12852255
Book value: 8535068.493150685
P/B ratio: 26.80355045581485
Market cap (USD): 228770139
Debt to equity: 0.2090649375662055
Current ratio: 1.9653743265136958
Quick ratio: 1.8639463471609963
Interest coverage ratio: -25.773936170212764
COGS to revenue (%): 86.97458213826525
R&D to revenue (%): 43.902680249233505
SG&A to revenue (%): 63.84136089407576
Free cash flow (dilution-adjusted): -6310958.904109589
Buyback yield (%): 0
Retained earnings: -56176986.30136986
Inventory turnover: 6.5334323922734026
Receivables turnover: 3.455570745044429
Capitalized R&D asset: 4768811.329277984
ROCI (R&D-adjusted, %): -30.285285322250516
Rosenberg metric: -0.12932225995292523
FCF margin (%): -113.91059242409256
Revenue growth (%): 7.330577870180452
Rule of 40 score: -106.58001455391211
Financial ratios for MDWD — quarterly report dated 2025-03-31
Total revenue: 1071815.7181571815
Gross profit: 200000
Operating income: -1415989.1598915989
Net income: -196747.9674796748
Capital expenditures: 259891.59891598916
Operating cash flow: -1113821.138211382
Depreciation & amortization: 97018.9701897019
Net tangible assets: 8452303.52303523
Owner earnings: -359620.59620596207
Return on net tangible assets (%): -4.2547051845201835
Buffett classification: The Gruesome
Stock price: 15.52
Shares outstanding: 12852255
Book value: 8474796.747967482
P/B ratio: 23.53649338526477
Market cap (USD): 199466997.6
Debt to equity: 0.20542338193911483
Current ratio: 2.1527262738634803
Quick ratio: 1.9888293732545896
COGS to revenue (%): 81.3400758533502
R&D to revenue (%): 72.97092288242732
SG&A to revenue (%): 77.69911504424779
Free cash flow (dilution-adjusted): -1602439.024390244
Buyback yield (%): 0
Inventory turnover: 0.8986033519553074
Receivables turnover: 0.7641035548686244
Capitalized R&D asset: 1330228.8896313622
ROCI (R&D-adjusted, %): -8.270186932328098
Rosenberg metric: -0.05793703951774951
FCF margin (%): -149.5069532237674
Revenue growth (%): -33.01151761517615
Rule of 40 score: -182.51847083894356
Financial ratios for MDWD — quarterly report dated 2025-06-30
Total revenue: 1683775.8112094395
Gross profit: 395870.2064896755
Operating income: -1686135.6932153392
Net income: -3928613.5693215337
Capital expenditures: 309439.52802359883
Operating cash flow: -1697935.1032448376
Depreciation & amortization: 116224.18879056047
Net tangible assets: 5915339.233038348
Owner earnings: -4121828.9085545717
Return on net tangible assets (%): -69.68034708023735
Buffett classification: The Gruesome
Stock price: 19.37
Shares outstanding: 12852255
Book value: 5934808.259587022
P/B ratio: 41.94713097055022
Market cap (USD): 248948179.35000002
Debt to equity: 0.4011133754162731
Current ratio: 1.4818547693577793
Quick ratio: 1.3496611743662068
Interest coverage ratio: -0.7556848228450556
COGS to revenue (%): 76.48913805185703
R&D to revenue (%): 61.15977575332866
SG&A to revenue (%): 62.49124036440084
Free cash flow (dilution-adjusted): -2261651.9174041296
Buyback yield (%): 0
Inventory turnover: 1.1360915951079884
Receivables turnover: 0.8394117647058824
Capitalized R&D asset: 1823776.8937747567
ROCI (R&D-adjusted, %): -11.780959927358955
Rosenberg metric: 0.25043695840156016
FCF margin (%): -134.32025227750523
Revenue growth (%): 57.09564458565948
Rule of 40 score: -77.22460769184576
Financial ratios for MDWD — quarterly report dated 2025-09-30
Total revenue: 1640181.2688821752
Gross profit: 270694.8640483384
Operating income: -1971299.093655589
Net income: -801208.4592145015
Capital expenditures: 315709.9697885196
Operating cash flow: -978549.8489425982
Depreciation & amortization: 126283.98791540785
Net tangible assets: 15137764.350453172
Owner earnings: -990634.4410876133
Return on net tangible assets (%): -6.544126451921926
Buffett classification: The Gruesome
Stock price: 18.02
Shares outstanding: 12852255
Book value: 15152870.09063444
P/B ratio: 15.284077122996253
Market cap (USD): 231597635.1
Debt to equity: 0.16490549485604913
Current ratio: 2.6484726136969603
Quick ratio: 2.4806886569665574
COGS to revenue (%): 83.49603978633266
R&D to revenue (%): 63.82390863879167
SG&A to revenue (%): 72.86793147909376
Free cash flow (dilution-adjusted): -1517824.7734138973
Buyback yield (%): 0
Inventory turnover: 1.0290578887627697
Receivables turnover: 0.899138787678039
Capitalized R&D asset: 1994887.0074549476
ROCI (R&D-adjusted, %): -8.31077333757099
Rosenberg metric: -0.12155382723464132
FCF margin (%): -92.54006262663474
Revenue growth (%): -2.5890942272148925
Rule of 40 score: -95.12915685384962
Financial ratios for MDWD — quarterly report dated 2025-12-31
Total revenue: 587106.9182389937
Gross profit: 87421.38364779874
Operating income: -2456918.2389937104
Net income: -2258805.0314465407
Capital expenditures: 771069.1823899371
Operating cash flow: -948427.6729559748
Depreciation & amortization: 216981.1320754717
Net tangible assets: 13710377.358490566
Owner earnings: -2812893.0817610063
Return on net tangible assets (%): -20.516525608385514
Buffett classification: The Gruesome
Stock price: 18.46
Shares outstanding: 12852255
Book value: 13720754.716981133
P/B ratio: 17.29151436592409
Market cap (USD): 237252627.3
Debt to equity: 0.18683535020168682
Current ratio: 2.332503500855765
Quick ratio: 2.1732923603547536
COGS to revenue (%): 85.10980182110337
R&D to revenue (%): 239.85002678093198
SG&A to revenue (%): 205.94536689876804
Free cash flow (dilution-adjusted): -1927672.9559748427
Buyback yield (%): 0
Retained earnings: -71988993.71069182
Inventory turnover: 0.38822379672611773
Receivables turnover: 0.7870994940978078
Capitalized R&D asset: 2449382.581392506
ROCI (R&D-adjusted, %): -10.285766630103659
Rosenberg metric: -0.1750750996034015
FCF margin (%): -328.33422603106584
Revenue growth (%): -64.2047541099453
Rule of 40 score: -392.53898014101117
Financial ratios for MDWD — annual report dated 2025-12-31
Total revenue: 5333018.867924528
Gross profit: 1023270.4402515723
Operating income: -7949371.069182389
Net income: -7509119.496855346
Capital expenditures: 1731132.075471698
Operating cash flow: -5069496.855345911
Depreciation & amortization: 584905.6603773584
Net tangible assets: 13710377.358490566
Owner earnings: -8655345.911949685
Return on net tangible assets (%): -63.12988830019036
Buffett classification: The Gruesome
Stock price: 18.46
Shares outstanding: 12852255
Book value: 13720754.716981133
P/B ratio: 17.29151436592409
Market cap (USD): 237252627.3
Debt to equity: 0.18683535020168682
Current ratio: 2.332503500855765
Quick ratio: 2.1732923603547536
Interest coverage ratio: -66.52368421052631
COGS to revenue (%): 80.81254790966449
R&D to revenue (%): 84.43894097529335
SG&A to revenue (%): 82.10979420956423
Free cash flow (dilution-adjusted): -7777987.421383647
Buyback yield (%): 0
Retained earnings: -71988993.71069182
Inventory turnover: 3.348399706816516
Receivables turnover: 7.149662731871838
Capitalized R&D asset: 6813498.298226398
ROCI (R&D-adjusted, %): -24.93138667491092
Rosenberg metric: 0.12400733351185388
FCF margin (%): -145.84586355327554
Revenue growth (%): -3.740881871602576
Rule of 40 score: -149.5867454248781
Financial ratios for MLHIN.PA — annual report dated 2021-12-31
Total revenue: 2791692.0454545454
Gross profit: 5415.909090909091
Operating income: -335189.7727272727
Net income: -271921.5909090909
Capital expenditures: 0
Depreciation & amortization: 614621.5909090909
Net tangible assets: 15093989.772727273
Owner earnings: 342700.00000000006
Buffett classification: The Gruesome
Stock price: 268
Shares outstanding: 58680
Book value: 15588348.863636365
P/B ratio: 1.008845782036948
Market cap (USD): 15726240
Debt to equity: 0.2688296409024018
Current ratio: 2.03344891613163
Quick ratio: 1.7995839019261313
Interest coverage ratio: -10.064728563141912
COGS to revenue (%): 99.8059990499408
Buyback yield (%): 0
Retained earnings: -2462351.1363636362
Inventory turnover: 15.636266819718129
Receivables turnover: 41.59649508973924
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6897408936406788
Rule of 40 score: 0
Financial ratios for MLHIN.PA — annual report dated 2022-12-31
Total revenue: 7060673.404255319
Gross profit: 2333894.680851064
Operating income: 378034.04255319154
Net income: 288695.74468085106
Capital expenditures: 0
Depreciation & amortization: 913196.8085106383
Net tangible assets: 14419239.36170213
Owner earnings: 1201892.5531914893
Return on net tangible assets (%): 8.335339493591782
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 288.8404255319149
P/E ratio: 58.70940768091268
Shares outstanding: 58680
Book value: 14882043.617021278
P/B ratio: 1.1388997779059884
Market cap (USD): 16949156.170212764
Debt to equity: 0.20411303898222052
Current ratio: 1.6557395082778725
Quick ratio: 1.3663925514946045
Interest coverage ratio: 14.027790936365072
COGS to revenue (%): 66.9451545592737
Buyback yield (%): 0
Retained earnings: -2016484.0425531915
Inventory turnover: 17.970434663032005
Receivables turnover: 54.72938896676837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.103673240852743
Revenue growth (%): 152.91734508294218
Rule of 40 score: 152.91734508294218
Financial ratios for MLHIN.PA — annual report dated 2023-12-31
Total revenue: 7430642.222222222
Gross profit: 2038592.2222222222
Operating income: 140862.22222222222
Net income: 287900
Capital expenditures: 0
Depreciation & amortization: 835457.7777777778
Net tangible assets: 14762276.666666666
Owner earnings: 1123357.7777777778
Return on net tangible assets (%): 7.609651296634537
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 226.8111111111111
P/E ratio: 46.228815560958665
Shares outstanding: 58680
Book value: 15255567.77777778
P/B ratio: 0.8724208888106497
Market cap (USD): 13309276
Debt to equity: 0.426176424767613
Current ratio: 2.028354462244163
Quick ratio: 1.684924003514881
Interest coverage ratio: 0.9490713360633034
COGS to revenue (%): 72.56506017574674
Buyback yield (%): 0
Retained earnings: -2394004.4444444445
Inventory turnover: 16.467850525644245
Receivables turnover: 38.19530638703745
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6433103507628679
Revenue growth (%): 5.23985173629374
Rule of 40 score: 5.23985173629374
Financial ratios for MLRZE.LS — annual report dated 2021-12-31
Total revenue: 1243298.7613636362
Net income: 70329.48863636363
Capital expenditures: 6616.488636363637
Operating cash flow: 487673.67045454547
Depreciation & amortization: 76069.13636363635
Net tangible assets: 364306.3522727273
Owner earnings: 139782.13636363635
Return on net tangible assets (%): 38.36939309227102
Buffett classification: The Gruesome
Stock price: 1.465909090909091
P/E ratio: 104.217243672034
Shares outstanding: 5000000
Book value: 479513.9659090908
P/B ratio: 15.285363880173271
Market cap (USD): 7329545.454545455
Debt to equity: 0.13313281779711178
Effective tax rate (%): 18.076415744325143
COGS to revenue (%): 0
SG&A to revenue (%): 37.74849296397539
Free cash flow (dilution-adjusted): 446012.8409090909
Buyback yield (%): 0
Retained earnings: -181249.60227272726
Receivables turnover: 3.6061752942612757
Capitalized R&D asset: 0
FCF margin (%): 35.873343943487
Rule of 40 score: 35.873343943487